Roll for Intervention - TBI Group Treatment

October 18, 2023 updated by: Louise Keegan, Moravian University

Roll for Intervention - a Critical Look at the Practicability of Table-top Roll Playing Games as Communication Intervention for Traumatic Brain Injury

Communication group intervention for individuals with Traumatic Brain Injury based on INSIGHT protocol (Keegan et al, 2020) with roll playing game focus

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Individuals with TBI recruited to participate in a study about applying INSIGHT protocol to a virtual roll playing game environment. The game 'monsters of the week' will be used to administer the cognitive-communication ingredients outlined by INSIGHT (Keegan et al 2020) and progress towards social communication goals will be documented throughout the course of participating in the roll playing campaign (7-8 weeks - meeting 2 hours each week). The individuals without neurological disorders will follow the same protocol.

Study Type

Observational

Enrollment (Actual)

5

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Bethlehem, Pennsylvania, United States, 18018
        • Moravian University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Group 1: individuals who have received a brain injury at least 1 year prior to enrollment.

Group 2: age, education and gender matched individuals who have no history of neurological difficulties

Description

Inclusion Criteria:

  • moderate to severe TBI more than 1 year ago

Exclusion Criteria:

  • other neurological diagnoses prior to TBI

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Individuals with TBI
See Keegan et al., 2020

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Goal Attainament Scaling - change over time
Time Frame: Week 2, 3,4,5,6,7, 8 and 9 of the 10week study protocol
Assessing change over time on five point scaled goals - goal rated each week for 8 weeks.
Week 2, 3,4,5,6,7, 8 and 9 of the 10week study protocol

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Repeatable Battery for the Assessment of Neuropsychological Status Update
Time Frame: During week 1 and week 10 of the 10 week protocol
Randolf (2012) standardized norm referenced assessment measure of cognitive skills (memory and attention etc.)
During week 1 and week 10 of the 10 week protocol
Functional Assessment of Verbal Reasoning and Executive Strategies
Time Frame: During week 1 and week 10 of the 10 week protocol
MacDonald (2005) standardized norm referenced assessment measure of problem solving and reasoning
During week 1 and week 10 of the 10 week protocol
Sydney psychosocial reintegration scale version 2 (SPRS-2)
Time Frame: During week 1 and week 10 of the 10 week protocol
Tate (2012) standardized likert based questionnaire (12, 1-5 ratings, where higher scores = better performance)
During week 1 and week 10 of the 10 week protocol
Satisfaction with life scale (SWLS)
Time Frame: During week 1 and week 10 of the 10 week protocol
Diener et al (1985), likert measurement scale questionnaire, 5 1-7 ratings, higher scores = better performance
During week 1 and week 10 of the 10 week protocol
Latrobe Communication Questionnaire (LCQ)
Time Frame: During week 1 and week 10 of the 10 week protocol
Douglas et al (2000), likert measurement scale questionnaire, 30 1-4 ratings, higher scores = better performance
During week 1 and week 10 of the 10 week protocol

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Louise C Keegan, Moravian University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 2, 2022

Primary Completion (Actual)

December 20, 2022

Study Completion (Actual)

May 1, 2023

Study Registration Dates

First Submitted

August 23, 2022

First Submitted That Met QC Criteria

August 25, 2022

First Posted (Actual)

August 26, 2022

Study Record Updates

Last Update Posted (Actual)

October 23, 2023

Last Update Submitted That Met QC Criteria

October 18, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Communication Disorder, Social

Clinical Trials on INSIGHT

Subscribe